Navigation Links
Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition

NEW YORK, May 3, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Probiotics and Prebiotics in Clinical Nutrition


Overall sales of clinical nutrition products are rising with an aging population in the US and EU as well as rising incidence of illnesses and conditions that require clinical nutrition. But sales of clinical nutrition products containing probiotics and prebiotics are outpacing sales of conventional clinical nutrition products, opening up a new market that is dominated by a handful of players.

Features and benefits

* Understand the clinical nutrition market and broad trends affecting product development and usage.

* Analyze the unmet need for pro/prebiotic clinical nutrition products and what is the supporting clinical data for product benefits?

* Identify the key players in the pro/prebiotic clinical nutrition market and the leading products in the market.

* Forecast the growth of the pro/prebiotic clinical nutrition market by users and product sales in the EU and the US.

* Assess the future of probiotics and prebiotics in clinical nutrition and the potential product development opportunities.


Nearly all of the major manufacturers of enteral nutrition products – Abbott Nutrition, Danone, Fresenius Kabi and Nestle – are currently working to expand their offerings of products containing probiotics and prebiotics. Currently, several clinical nutrition products are formulated with prebiotics and one major product contains probiotics.

Several special patient populations are especially good candidates for clinical nutrition products containing probiotics and/or prebiotics as they have specific and/or greater nutritional needs than non-elderly adults. They include the elderly, patients with compromised gastrointestinal systems, the critically ill and infants.

Although there is interest and activity in the development of enteral nutrition products containing probiotics, a lack of basic research establishing the clinical performance of probiotics in enteral nutrition patients is limiting further new product activity.

Your key questions answered

* Why are clinical nutrition products now incorporating probiotic and prebiotic ingredients? What types products are most amenable to reformulation?

* What benefits can probiotic and prebiotic ingredients provide in clinical nutrition products that is not otherwise available?

* What clinical nutrition products currently contain probiotic and prebiotic ingredients?

* Which patient groups/market segments are most attractive for these products?

* What is the forecast growth of clinical nutrition products containing probiotics and prebiotics and what are the drivers/inhibitors of R&D?

Executive Summary

Introduction to clinical nutrition

Probiotics and their role in healthcare

Usage of probiotics and prebiotics in clinical nutrition

Activities of the major players in probiotics and prebiotics

About the author


Introduction to clinical nutrition



Major types of clinical nutrition

Enteral nutrition

Parenteral nutrition

Infant nutrition

Patient populations

Cancer patients

Gastrointestinal disease patients

AIDS patients

Patients with neuromuscular conditions

Malnutrition patients

Other clinical nutrition patients

Environments for clinical nutrition

Inpatient environments

Outpatient environments

Regulation of clinical nutrition products



Insurance coverage


User populations


The evolving role of probiotics in healthcare






Factors affecting probiotic levels in the human body

Declining levels of probiotics in food

Types of probiotic organisms

Safety issues



Benefits of probiotics and prebiotics


Colon cancer


Gastrointestinal disease and diarrhea

Helicobacter pylori


Immune system function

Lactose intolerance

Mineral absorption

Urinary tract infections

Yeast infections

Disadvantages of probiotics



Patent issues

Regulation of probiotic and prebiotic products



Other industry issues


Testing protocols

Consumers' ability to self-diagnose

Current products



User populations




Usage of probiotics and prebiotics in clinical nutrition



Special populations

The elderly

Patients with compromised gastrointestinal systems

The critically ill


Safety issues

Current products

Products under development

Parenteral nutrition

Infant nutrition

Sales forecasts, 2010 - 2015

Total probiotic supplement sales by region, 2010 - 2015

Total prebiotic supplement sales by region, 2010–2015

Sales of clinical nutrition products containing probiotics, 2010–2015

Sales of clinical nutrition products containing prebiotics, 2010 - 2015


Activities of the major players in probiotic and prebiotic clinical nutrition products



Leading suppliers of clinical nutrition products

Abbott Laboratories

B. Braun


Fresenius Kabi



The future of probiotics and prebiotics in clinical nutrition





Secondary research



To order this report:

: Probiotics and Prebiotics in Clinical Nutrition

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer
2. Reportlinker Adds Cancer Reports Bundle
3. Reportlinker Adds Medical Imaging Technologies for Oncology Diagnostics: The Global Market
4. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
5. Reportlinker Adds Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists Survey
6. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
7. Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
8. Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify
9. Reportlinker Adds Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
10. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
11. Reportlinker Adds Forecast Insight: Antibacterials
Post Your Comments:
(Date:11/30/2015)... 30, 2015 Varian Medical Systems (NYSE: VAR ) ... partnership with Apollo Hospitals Group, the largest hospital chain in ... train radiation technologists in the country. The MoU was signed by ... and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access to ...
(Date:11/30/2015)... and BOSTON , November ... research and develop potential new medicines directed at up ... therapeutic areas. --> PFE ) to research ... 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic ... GPCR structure-guided drug discovery and development company and wholly-owned ...
(Date:11/29/2015)... Nov. 29, 2015  Strengthening its leadership in connected ... PHIA) today announced IntelliSpace Portal 8.0 , the ... visualization platform that helps radiologists detect, diagnose and follow-up ... Radiological Society of North America Annual Meeting (RSNA) ... 8.0 helps address the changing demands in radiology that ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... Two years ago, Debbie Gregory, the CEO of, found herself ... Meditation (TM). After encouraging a number of veterans to go through the program, ... the talk. , TM is becoming one of the best alternative treatments for Post-Traumatic ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to ... Ph.D., a senior scientist at Consumer Reports as supporting a “A Call for ... exposure limits. , The original Nov 2015 CR story titled, “Does Cell-Phone Radiation ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... at the Radiology Society of North America (RSNA) annual meeting, being held November ... growth from 2014. Throughout 2015, the company has completed installations for Integrated ...
(Date:11/30/2015)... ... ... It’s inevitable that everyone will experience death in his or her lifetime. Whether ... among us. It is your perspective, however, that determines how you view death in ... Sky understands that she may see death more frequently than most. As she was ...
(Date:11/30/2015)... Morton Grove, IL (PRWEB) , ... November 30, 2015 , ... ... milestone for an emerging pharmaceutical company. Because it is so important to this key ... titled “Success Factors in your IND Filing” on December 4th at 11am EST. , ...
Breaking Medicine News(10 mins):